Speciality Generic Injectables
Narender Dev Mantena
Head, Global Strategy & CEO, Specialty Generic Injectables & Synthetic Biology
Narender Mantena has been associated with Biological E. Limited since 1992. He has been responsible for forging key alliances with GSK, Merck and Intercell. He laid the road map for the company’s foray into the regulated markets. He also championed the complex/routine injectables, novel vaccines and synthetic biology initiatives at Biological E. Limited. Narender Mantena holds a Master’s Degree in Engineering from Michigan State University.
Dr. Vishvesh Kumar Bhupathiraju
COO, Pharma Specialty Generic Injectables
Dr. Vishvesh has joined us with over 30 years of global work experience in leading biopharmaceutical companies and academic institutions in the areas of Commercial Manufacturing, Pilot Scale Manufacturing, Projects, Program Management, SCM, QA, QC, RA and others.
Prior to joining us, he was associated with Stelis Biopharma in Bengaluru as their Chief Operating Officer. Earlier, he worked with Dr. Reddy’s Laboratories at their Biologics Division in Hyderabad, and Bayer Healthcare in the US. He also had a stint in academic and research institutions in the US.
Dr. Vishvesh holds a dual Bachelor’s degree in Genetics from Osmania University, Bachelor’s and Master’s degrees along with a Ph.D in Microbiology from the University of Oklahoma, USA. He also has a Post Doctorate in Environmental Engineering from the University of California, Berkeley, USA.
Bill Hill
President
Bill brings more than 20 years of generic and brand pharma experience to BE Pharmaceuticals Inc. Bill was part of the successful US market entry with Endo, Dr. Reddy’s and Alvogen. Leading the commercial team at Alvogen, the group won 6 consecutive HDMA awards as top supplier and multiple large customer best-in-class awards. Bill is President, US Commercial Operations of BE Pharmaceuticals Inc. Bill has a Bachelor’s Degree in Business / Marketing from the University of Lynchburg.